Cadrenal Therapeutics, Inc. (CVKD): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 1-for-15, first reflected in a filing dated 2024-11-07. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

1.99M
Year ended 2025-12-31
2023-12-31: 899.5K2024-12-31: 1.22M2025-12-31: 1.99M1.99M
2023-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-311.99M+63.5%2026-03-31, From 2025-01-01
2024-12-311.22M+35.6%2026-03-31, From 2024-01-01
2023-12-31899.5Kn/a2025-03-13, From 2023-01-01